Verigene(R) Enteric Pathogens Test Receives FDA Clearance
24 juin 2014 18h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., June 24, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing the practice of medicine through targeted molecular diagnostics, today announced it has received...
Nanosphere Signs Molecular Diagnostic Supply Agreement With HealthTrust
23 juin 2014 08h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., June 23, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it has been selected by...
Twelve Studies Presented at ASM 2014 Highlight New Performance and Clinical Outcome Data Using Select Verigene Infectious Disease Tests
21 mai 2014 08h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., May 21, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that twelve studies evaluating...
New Performance and Clinical Outcome Data from Twelve Studies Using Nanosphere's Infectious Disease Tests to be Presented at ASM 2014
16 mai 2014 08h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., May 16, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that new performance and...
Studies Presented at ECCMID 2014 Highlight Accuracy and Potential Clinical Utility of Several Nanosphere Infectious Disease Tests
14 mai 2014 08h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., May 14, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that six studies performed by...
New Validation and Clinical Outcome Data From Several Studies Using Nanosphere's Infectious Disease Tests to be Presented at ECCMID 2014
08 mai 2014 08h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., May 8, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that new validation and clinical...
Nanosphere Announces First Quarter Financial and Operating Results
07 mai 2014 08h00 HE
|
Nanosphere, Inc.
Corporate Highlights and Business Guidance:
Achieved 48 new Verigene® customer placements
Achieved Q1 2014 revenues of $3.3 million, a 39% increase over Q1 2013
Reaffirmed 2014...
Nanosphere to Release First Quarter Results and Host Investor Conference Call on Wednesday, May 7, 2014
17 avr. 2014 08h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., April 17, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report its...
Nanosphere Clarifies Recent Transactions in Company's Common Stock
04 avr. 2014 18h30 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., April 4, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH) today clarified recent transactions in Nanosphere's common stock by certain of its directors and significant...
Nanosphere to Present at the 13th Annual Needham Healthcare Conference
03 avr. 2014 17h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., April 3, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that that an overview of the...